Biogen Idec Inc. (BIIB) on Friday reported second-quarter profit of $927.3 million.
On a per-share basis, the Cambridge, Massachusetts-based company said it had net income of $3.93. Earnings, adjusted for one-time gains and costs, were $4.22 per share.
Continue Reading Below
The results topped Wall Street expectations. The average estimate of 19 analysts surveyed by Zacks Investment Research was for earnings of $4.10 per share.
The biotechnology company posted revenue of $2.59 billion in the period, which missed Street forecasts. Eighteen analysts surveyed by Zacks expected $2.71 billion.
Biogen expects full-year earnings in the range of $15.50 to $15.95 per share.
Biogen shares have risen 13 percent since the beginning of the year, while the Standard & Poor's 500 index has climbed 2 percent. The stock has climbed 24 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BIIB at http://www.zacks.com/ap/BIIB
Keywords: Biogen Idec, Earnings Report